相关实验视频
Updated: Sep 15, 2025

13:28
Methodology for Sputum Induction and Laboratory Processing
Published on: December 17, 2017
27.9K
在Mepolizumab治疗的城市儿童中残留喘恶化中的炎症途径:随机临床试验的二次分析
Matthew C Altman1,2, Tomasz Janczyk2, Ryan C Murphy1
1Department of Medicine, University of Washington, Seattle.
JAMA pediatrics
|July 14, 2025
概括
儿童喘的生物疗法可以减少恶化,但不能消除它们. 这项研究揭示了其他炎症途径,包括表皮和巨细胞的参与,导致持续性喘恶化.
科学领域:
- 儿科过敏和免疫学
- 呼吸系统医学 呼吸系统医学
- 分子医学是分子医学.
背景情况:
- 针对2型 (T2) 炎症的生物疗法用于儿童喘,但由于对分子机制的了解不足,急性恶化仍然存在.
- 识别这些机制对于改善患有恶化倾向的儿科喘治疗结果至关重要.
研究的目的:
- 为了确定不同分子机制的基础上喘恶化在城市儿童患有eosinophilic喘.
- 在接受梅波利祖马布治疗的儿童中描述呼吸系统疾病及其分子特征与安慰剂.
主要方法:
- 对MUPPITS-2随机临床试验的二次分析,该试验涉及患有易恶化的喘的儿童.
- 在急性呼吸道疾病期间,通过RNA测序鼻腔样本进行转录学模块化分析.
- 研究了上呼吸道转录特征,临床结果和肺功能之间的关联.
主要成果:
- 与安慰剂相比,梅波利祖马布减少了T2炎症标志物,但在恶化期间增加了表皮质和巨细胞炎症途径.
- 这两组在恶化期间都显示出粘液分泌量增加和细胞应激通路.
- 涉及表皮,巨细胞和粘液过分分泌的明显的炎症轴被确定为恶化异质性的关键驱动因素.
结论:
- 多种替代性炎症途径 (表皮,巨细胞,粘液高分泌) 导致儿童治疗梅波利祖马布的残留喘恶化.
- 独特的炎症轴可以独立地驱动喘恶化,突出显示了疾病的复杂性.
相关概念视频
Asthma: Pathogenesis and Management
606
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
606
Asthma-II: Pathophysiology and Classification
2.9K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.9K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
471
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
471
Antiasthma Drugs: Leukotriene Modifiers
486
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
486
Asthma-I: Introduction
2.8K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
Asthma-III: Symptoms and Complications
2.6K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.6K

